Cancer Treatment and Nanomedicine
2025/2026 Exam Questions with 100%
Correct Answers | Latest Update
Cancer - 🧠ANSWER ✔✔Leading cause of death worldwide
Cancer treatment modalities - 🧠ANSWER ✔✔Surgery, radiation,
chemotherapy
Chemotherapy - 🧠ANSWER ✔✔Not highly efficient in killing tumor cells
Pharmacokinetics - 🧠ANSWER ✔✔Study of drug movement within the body
Chemotherapy drugs - 🧠ANSWER ✔✔Poor pharmacokinetics and systemic
toxicities
Advantages of nanomedicine - 🧠ANSWER ✔✔Longer circulation time,
reduced side effects, controlled and sustained drug release
EPR effect - 🧠ANSWER ✔✔Enhanced permeability and retention in tumors
Liposome - 🧠ANSWER ✔✔Composed of a phospholipid bilayer
1
COPYRIGHT©JOSHCLAY 2025/2026. YEAR PUBLISHED 2025. COMPANY REGISTRATION NUMBER: 619652435. TERMS OF USE. PRIVACY
STATEMENT. ALL RIGHTS RESERVED
, Liposome encapsulation - 🧠ANSWER ✔✔Can encapsulate both
hydrophobic and hydrophilic drugs
Polymeric micelle - 🧠ANSWER ✔✔Made up of biosurfactant with
hydrophobic tail
Currently approved nanocarriers - 🧠ANSWER ✔✔Use biologically
functional materials
Polyethylene glycol (PEG) - 🧠ANSWER ✔✔Not hydrophobic
PEGylation - 🧠ANSWER ✔✔Increases drug size, improves solubility,
avoids recognition/binding of mononuclear phagocyte system
Paclitaxel (PTX) - 🧠ANSWER ✔✔Natural product chemodrug
Taxol - 🧠ANSWER ✔✔Formulated in 50% cremophor EL and 50% ethanol
Abraxane - 🧠ANSWER ✔✔Albumin-bound paclitaxel nanoformulation
Embelin (EB) - 🧠ANSWER ✔✔Hydrophobic and natural product anticancer
drug
PEG-EB2 - 🧠ANSWER ✔✔Increases water solubility of EB and self-
assembles into liposome
2
COPYRIGHT©JOSHCLAY 2025/2026. YEAR PUBLISHED 2025. COMPANY REGISTRATION NUMBER: 619652435. TERMS OF USE. PRIVACY
STATEMENT. ALL RIGHTS RESERVED
2025/2026 Exam Questions with 100%
Correct Answers | Latest Update
Cancer - 🧠ANSWER ✔✔Leading cause of death worldwide
Cancer treatment modalities - 🧠ANSWER ✔✔Surgery, radiation,
chemotherapy
Chemotherapy - 🧠ANSWER ✔✔Not highly efficient in killing tumor cells
Pharmacokinetics - 🧠ANSWER ✔✔Study of drug movement within the body
Chemotherapy drugs - 🧠ANSWER ✔✔Poor pharmacokinetics and systemic
toxicities
Advantages of nanomedicine - 🧠ANSWER ✔✔Longer circulation time,
reduced side effects, controlled and sustained drug release
EPR effect - 🧠ANSWER ✔✔Enhanced permeability and retention in tumors
Liposome - 🧠ANSWER ✔✔Composed of a phospholipid bilayer
1
COPYRIGHT©JOSHCLAY 2025/2026. YEAR PUBLISHED 2025. COMPANY REGISTRATION NUMBER: 619652435. TERMS OF USE. PRIVACY
STATEMENT. ALL RIGHTS RESERVED
, Liposome encapsulation - 🧠ANSWER ✔✔Can encapsulate both
hydrophobic and hydrophilic drugs
Polymeric micelle - 🧠ANSWER ✔✔Made up of biosurfactant with
hydrophobic tail
Currently approved nanocarriers - 🧠ANSWER ✔✔Use biologically
functional materials
Polyethylene glycol (PEG) - 🧠ANSWER ✔✔Not hydrophobic
PEGylation - 🧠ANSWER ✔✔Increases drug size, improves solubility,
avoids recognition/binding of mononuclear phagocyte system
Paclitaxel (PTX) - 🧠ANSWER ✔✔Natural product chemodrug
Taxol - 🧠ANSWER ✔✔Formulated in 50% cremophor EL and 50% ethanol
Abraxane - 🧠ANSWER ✔✔Albumin-bound paclitaxel nanoformulation
Embelin (EB) - 🧠ANSWER ✔✔Hydrophobic and natural product anticancer
drug
PEG-EB2 - 🧠ANSWER ✔✔Increases water solubility of EB and self-
assembles into liposome
2
COPYRIGHT©JOSHCLAY 2025/2026. YEAR PUBLISHED 2025. COMPANY REGISTRATION NUMBER: 619652435. TERMS OF USE. PRIVACY
STATEMENT. ALL RIGHTS RESERVED
